Introduction
Pleural empyema—the collection of frank pus within
the pleural cavity—represents an advanced and dangerous stage of pleural infection. While often originating as a complication of community-
acquired or hospital-acquired pneumonia (parapneumonic
effusion), empyema can also develop secondary to thoracic trauma, surgical procedures, esophageal perforation, or
subdiaphragmatic abscesses.
Left untreated or inadequately managed, empyema transitions from a fluid-based inflammatory collection to a rigid, fibrous process that traps the lung, compromises respiratory mechanics, and leads to persistent systemic sepsis. Understanding the stage of the disease is crucial, as timing directly dictates whether conservative management will suffice or if advanced surgical intervention is required.
Staging and Pathophysiology
The American Thoracic Society classifies pleural empyema into three distinct, progressive stages:
| Stage | Name | Key Characteristics | Preferred Management Strategy |
| Stage 1 | Exudative Phase | Thin, clear fluid accumulates; low cellular content; lung expands fully. | Antibiotics + Tube Thoracostomy (Chest Drain) |
| Stage 2 | Fibrinopurulent Phase | Pus develops; heavy fibrin deposition forms septations and “loculations” (pockets). | Image-guided drainage, intrapleural fibrinolytics, or early VATS |
| Stage 3 | Organizational Phase | Dense fibrous tissue forms a thick “peel” over the visceral pleura, trapping the lung. | Surgical Decortication (VATS or Open Thoracotomy) |
Therapeutic Treatment Pathways
Effective management of empyema relies on two fundamental principles: controlling the source of infection through targeted antimicrobial therapy and achieving complete pleural space source control (evacuating pus and allowing the lung to fully re-expand).
1. Broad-Spectrum Antimicrobial Therapy
Empiric intravenous antibiotics must be initiated immediately upon suspicion, later tailored based on pleural fluid cultures and sensitivities. Because pleural fluid penetration varies, regimens usually cover common respiratory pathogens, including anaerobes, Streptococcus pneumoniae, Staphylococcus aureus (including MRSA), and Gram-negative bacilli.
2. Tube Thoracostomy s Intrapleural Fibrinolysis
- ChestTubeDrainage:Placing an intercostal drain is the first line of defense for free-flowing infected effusions.
- Intrapleural Fibrinolytic Therapy (MIST-2 Protocol): In Stage 2 empyema with multiple loculations, instilling tissue plasminogen activator (tPA) combined with human
recombinant DNase directly into the chest tube can help break down fibrin webs and viscous pus, potentially avoiding surgery in select high-risk patients.
Surgical Interventions for Empyema
When medical management and simple chest tube drainage fail to clear the infection or re-expand the lung, thoracic surgery
becomes mandatory.
Surgical Goals
- Complete evacuation of infected fluid, pus, and necrotic debris.
- Breakdown of all intrapleural loculations and septations.
- Excision of the thick fibrous membrane (decortication) to free the trapped lung, allowing it to re-fill the chest cavity.
Surgical Techniques
VATS Decortication
Modern thoracic practice heavily favors minimally invasive VATS (or Uniportal VATS). Through small ports, the surgeon utilizes
specialized instruments to scrape away the thick fibrin peel from both the visceral pleura (lung surface) and parietal pleura (chest wall surface).
Open Decortication
In cases where chronic inflammation has created dense,
vascularized tissue that risks massive bleeding or pulmonary tearing during VATS, converting to an open thoracotomy ensures patient safety and complete surgical clearance.
Postoperative Management and Recovery
Following surgical decortication, patients are typically monitored in a specialized thoracic ward or step-down unit.
- Chest Drain Management: One or two large-bore chest
tubes remain in place connected to continuous low suction (−10 to −20 cmH2O) to drain lingering fluid and ensure the lung stays fully expanded against the chest wall.
- Aggressive Pulmonary Rehabilitation: Early mobilization, incentive spirometry, and chest physiotherapy are started on Postoperative Day 1 to promote lung recruitment and prevent atelectasis.
- Antibiotic Duration: Intravenous antibiotics are continued postoperatively and often transitioned to oral therapy for an additional 2 to 4 weeks upon discharge, depending on
clinical resolution and inflammatory markers (CRP and white blood cell count).
Frequently Asked Questions (FAQs)
What is the main difference between a parapneumonic effusion and an empyema?
A parapneumonic effusion is any fluid accumulation in the pleural space that occurs secondary to pneumonia. Initially, this fluid is sterile and clear (uncomplicated). If
bacteria migrate into this fluid, it becomes complicated. When the pleural fluid contains visible pus, has a foul odor, or tests positive for bacteria on Gram stain or culture, it is formally defined as an empyema.
Why can’t empyema be treated with antibiotics alone?
Antibiotics alone are rarely effective for empyema because infected pleural fluid becomes thick, acidic, and compartmentalized by fibrin walls. This localized
environment impairs antibiotic penetration and neutralizes white blood cell activity. Without physical drainage or surgical removal of the pus (“source control”), the infection will persist.
When is surgery necessary for empyema?
Surgery is indicated when:
- Chest tube drainage fails to evacuate the infected space due to thick pus or loculations.
- CT imaging shows a trapped lung caused by a thick fibrous peel (Stage 3 empyema).
- Systemic sepsis persists despite appropriate intravenous antibiotics and tube thoracostomy.
What are the risks of delaying surgery for a trapped lung?
Delaying surgical intervention allows the fibrous peel covering the lung to become
increasingly rigid and vascularized. This can lead to permanent loss of lung volume, chronic fibrothorax, chest wall deformity, persistent systemic infection, or the formation of a bronchopleural fistula (an abnormal passage between the lung’s airways and the pleural space).
How long is the recovery period after VATS decortication?
Hospital stays after VATS decortication typically range from 4 to 7 days, largely
depending on how quickly the lung re-expands and chest tube drainage subsides. Most patients can return to light daily activities within 2 to 3 weeks, though full energy
recovery and return to vigorous physical activity or work may take 4 to 6 weeks.
